A US Food and Drug Administration (FDA)-approved prescription video games to enhance cognitive function among children with attention deficit-hyperactivity disorder is now being considered as a treatment for adults with COVID “brain fog.” Such condition is seen in people who have recovered from COVID 19 and have since exhibited lingering cognitive symptoms, such as difficulties in paying attention and memory loss. The game, titled EndeavorRx, is now under rigorous testing to determine if the game is effective in enhancing cognitive symptoms in survivors of COVID-19. Game developer Akii Interactive looks forward to having the game authorized as a treatment for several cognitive conditions, such as mild cognitive impairment and dementia. |